Carrico Thomas Joeseph 4
4 · Neuraxis, INC · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Neuraxis (NRXS) CRO Thomas Carrico Receives RSU Award
What Happened
Thomas Carrico (CRO, CCO, CPO) was granted 47,569 restricted stock units (RSUs) on 2026-01-22 as compensation. The grant is reported at a per-share value of $4.63, totaling $220,244. This was an award (not an open-market purchase or sale) and represents a derivative compensation grant rather than an immediate change in tradable shares.
Key Details
- Transaction date: 2026-01-22; Form 4 filed 2026-02-26 (filed 35 days after the grant — outside the typical 2-business-day Form 4 window).
- Grant: 47,569 RSUs valued at $4.63 each; total reported value $220,244. (Transaction code: A — Award/Grant/Other acquisition)
- Shares owned after transaction: Not specified in the filing.
- Footnote: RSUs were granted under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan; they vest in three equal annual installments over three years.
- Filing timeliness: The Form 4 was filed late relative to the standard two-business-day reporting requirement.
Context
RSUs are a form of deferred compensation that convert into common stock only as they vest and typically remain subject to transfer restrictions until then; this grant does not represent a market purchase or sale. Such awards are common for executives and are intended as compensation or retention incentives rather than direct signals to buy or sell stock.
Insider Transaction Report
- Award
RSU
[F1]2026-01-22$4.63/sh+47,569$220,244→ 47,569 total→ Common Stock (47,569 underlying)
Footnotes (1)
- [F1]These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period.